Survey of 379 surgeons across ASES, AANA, and AOSSM capturing outcomes of 14,277 thermal capsulorrhaphy procedures performed over five years, with the goal of defining complication rates — specifically recurrent instability, capsular attenuation at revision, and axillary nerve injury — across laser, monopolar RF, and bipolar RF modalities.
When counseling patients before thermal capsulorrhaphy, quote ~8% recurrence risk and 1.4% axillary neuropathy risk — and warn that if they fail and need revision, one in five will have capsular attenuation requiring augmentation.
Post-op, restrict high-demand activity for 12 weeks while the capsule mechanically recovers, and balance early motion against avoiding restretch to prevent adhesive capsulitis.
Survey of 379 surgeons across ASES, AANA, and AOSSM capturing outcomes of 14,277 thermal capsulorrhaphy procedures performed over five years, with the goal of defining complication rates — specifically recurrent instability, capsular attenuation at revision, and axillary nerve injury — across laser, monopolar RF, and bipolar RF modalities.
When counseling patients before thermal capsulorrhaphy, quote ~8% recurrence risk and 1.4% axillary neuropathy risk — and warn that if they fail and need revision, one in five will have capsular attenuation requiring augmentation.
Post-op, restrict high-demand activity for 12 weeks while the capsule mechanically recovers, and balance early motion against avoiding restretch to prevent adhesive capsulitis.